Know Cancer

or
forgot password

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients


N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information

Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients


Inclusion Criteria:



- Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer
treated at MSKCC, including stages of disease I-IV

- 18 years of age or older

- Fluent in English or Spanish

- Patients must reside in the U.S

Exclusion Criteria:

- Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g.,
Philippines-born individuals)

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

psychosocial issues

Outcome Description:

related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

William Alago, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

11-109

NCT ID:

NCT01466946

Start Date:

November 2011

Completion Date:

November 2013

Related Keywords:

  • Lung Cancer
  • lung cancer
  • Hispanic/Latino patients
  • interviews
  • 11-109
  • Lung Neoplasms

Name

Location
Memorial Sloan Kettering Cancer Center New York, New York  10021